BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sansone S, Guarino M, Castiglione F, Rispo A, Auriemma F, Loperto I, Rea M, Caporaso N, Morisco F. Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(13): 3516-3524 [PMID: 24707134 DOI: 10.3748/wjg.v20.i13.3516]
URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3516.htm
Number Citing Articles
1
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, Paola Begini, Michela Ileen Biondo, Sara Caporuscio, Vincenzo Colonna, Francesca Della Casa, Paola Conigliaro, Cinzia Marrese, Eleonora Celletti, Irene Modesto, Mario Stefano Peragallo, Bruno Laganà, Andrea Picchianti-Diamanti, Roberta Di Rosa, Claudia Ferlito, Simonetta Salemi, Raffaele D’Amelio, Tommaso Stroffolini. Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in ItalyMicroorganisms 2020; 8(11): 1792 doi: 10.3390/microorganisms8111792
2
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
3
Maria Guarino, Marco Picardi, Anna Vitiello, Novella Pugliese, Matilde Rea, Valentina Cossiga, Fabrizio Pane, Nicola Caporaso, Filomena Morisco. Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for LymphomaAnnals of Hepatology 2017; 16(2): 198 doi: 10.5604/16652681.1231579
4
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi. Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control StudyPathogens 2020; 9(11): 870 doi: 10.3390/pathogens9110870
5
Igor Snast, Lihi Atzmony, Marius Braun, Emmilia Hodak, Lev Pavlovsky. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literatureJournal of the American Academy of Dermatology 2017; 77(1): 88 doi: 10.1016/j.jaad.2017.01.037
6
Julie J. Hong, Edward K. Hadeler, Megan L. Mosca, Nicholas D. Brownstone, Tina Bhutani, Wilson J. Liao. TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis: Therapeutic Utility in the Era of IL-17 and IL-23 InhibitorsJournal of Psoriasis and Psoriatic Arthritis 2022; 7(2): 79 doi: 10.1177/24755303211047479
7
Nicola Imperatore, Fabiana Castiglione, Antonio Rispo, Anna Sessa, Nicola Caporaso, Filomena Morisco. Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel DiseasesFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00867
8
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysisIntestinal Research 2023; 21(3): 392 doi: 10.5217/ir.2022.00094
9
Pilar López-Serrano, Elsa de la Fuente Briongos, Elisa Carrera Alonso, Jose Lázaro Pérez-Calle, Conrado Fernández Rodríguez. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapyWorld Journal of Hepatology 2015; 7(3): 539-547 doi: 10.4254/wjh.v7.i3.539
10
Shivani B. Kaushik, Mark G. Lebwohl. Psoriasis: Which therapy for which patientJournal of the American Academy of Dermatology 2019; 80(1): 43 doi: 10.1016/j.jaad.2018.06.056
11
Jing Fang, Wenge Li, Xiangxin Peng, Zhao Tan, Min Tan, Cong Zhang, Wenbo Wang, Zhihong Xu, Gumin Zhou. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysisInternational Urology and Nephrology 2017; 49(3): 475 doi: 10.1007/s11255-016-1487-5
12
Marco Fiore, Sebastiano Leone, Alberto Enrico Maraolo, Emilio Berti, Giovanni Damiani. Liver Illness and Psoriatic PatientsBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140983
13
Wei Huang, Lingyao Du, Hong Tang. Hepatitis B Virus Reactivation: Overview and ManagementFuture Virology 2021; 16(12): 821 doi: 10.2217/fvl-2021-0275
14
Claudio Bonifati, Viviana Lora, Dario Graceffa, Lorenzo Nosotti. Management of psoriasis patients with hepatitis B or hepatitis C virus infectionWorld Journal of Gastroenterology 2016; 22(28): 6444-6455 doi: 10.3748/wjg.v22.i28.6444
15
Martin Feuchtenberger, Arne Schäfer, Axel Philipp Nigg, Michael Rupert Kraus. Hepatitis B Serology in Patients with Rheumatic DiseasesThe Open Rheumatology Journal 2016; 10(1): 39 doi: 10.2174/1874312901610010039
16
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current ApproachGastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
17
Cassandra Michelle Skinner-Taylor, Alejandro Erhard-Ramírez, Mario Alberto Garza-Elizondo, Jorge Antonio Esquivel-Valerio, Carlos Abud-Mendoza, Marco Ulises Martínez-Martínez, David Vega-Morales, Ana Arana-Guajardo. Are RA patients from a non-endemic HCV population screened for HCV? A cross-sectional analysis of three different settingsReumatología Clínica (English Edition) 2017; 13(3): 156 doi: 10.1016/j.reumae.2016.03.016
18
Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliary manifestations in inflammatory bowel disease: A practical approachWorld Journal of Hepatology 2022; 14(2): 319-337 doi: 10.4254/wjh.v14.i2.319
19
Toru Ogura, Chihiro Shiraishi. Efficacy of Prednisone Avoidance in Patients With Liver Transplant Using the U.S. Food and Drug Administration Adverse Event Reporting SystemCureus 2024;  doi: 10.7759/cureus.60193
20
Cem Cekic, Fatih Aslan, Adnan Kirci, Zeynep Zehra Gümüs, Mahmut Arabul, Elif Sartas Yüksel, Sezgin Vatansever, Süreyya Gül Yurtsever, Emrah Alper, Belks Ünsal. Evaluation of Factors Associated With Response to Hepatitis B Vaccination in Patients With Inflammatory Bowel DiseaseMedicine 2015; 94(22): e940 doi: 10.1097/MD.0000000000000940
21
Cassandra Michelle Skinner-Taylor, Alejandro Erhard-Ramírez, Mario Alberto Garza-Elizondo, Jorge Antonio Esquivel-Valerio, Carlos Abud-Mendoza, Marco Ulises Martínez-Martínez, David Vega-Morales, Ana Arana-Guajardo. Are RA patients from a non-endemic HCV population screened for HCV? A cross-sectional analysis of three different settingsReumatología Clínica 2017; 13(3): 156 doi: 10.1016/j.reuma.2016.03.006
22
Mao-Xin Huang, Cai-Yun Wang, Jin-Yan Guo, Jian-Hao Li, Xiao-Hong Li, Jiang-An Zhang, Jian-Bin Yu. Pharmacotherapy for Behçet’s Disease and the Risk of MalignancyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.661150
23
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo, Maria Rendina. Liver involvement in inflammatory bowel disease: What should the clinician know?World Journal of Hepatology 2021; 13(11): 1534-1551 doi: 10.4254/wjh.v13.i11.1534
24
E‐Poster Presentations ‐ A4) Lower GIJournal of Gastroenterology and Hepatology 2017; 32(S3): 106 doi: 10.1111/jgh.13877
25
Niloofar Khoshnam-Rad, Homayoon Vahedi, Anahita Sadeghi, Mansoor Rastegarpanah, Soha Namazi, Amir Anushiravani, Ali Reza Sima, Shabnam Shahrokh, Sudabeh Alatab, Reza Malekzadeh. Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel DiseasesMiddle East Journal of Digestive Diseases 2023; 15(2): 83 doi: 10.34172/mejdd.2023.327
26
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Flavio Caprioli, Fabiana Castiglione, Michele Comberlato, Mario Cottone, Silvio Danese, Marco Daperno, Renata D’Incà, Giuseppe Frieri, Walter Fries, Paolo Gionchetti, Anna Kohn, Giovanni Latella, Monica Milla, Ambrogio Orlando, Claudio Papi, Carmelina Petruzziello, Gabriele Riegler, Fernando Rizzello, Simone Saibeni, Maria Lia Scribano, Maurizio Vecchi, Piero Vernia, Gianmichele Meucci, Annalisa Aratari, Fabrizio Bossa, Maria Cappello, Andrea Cassinotti, Alberto Chiriatti, Gionata Fiorino, Vincenzo Formica, Luisa Guidi, Alessandra Losco, Filippo Mocciaro, Sara Onali, Luca Pastorelli, Roberta Pica, Mariabeatrice Principi, Sara Renna, Chiara Ricci, Antonio Rispo, Francesca Rogai, Loredana Sarmati, Franco Scaldaferri, Luisa Spina, Rosy Tambasco, Anna Testa, Angelo Viscido. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Digestive and Liver Disease 2017; 49(4): 338 doi: 10.1016/j.dld.2017.01.141
27
Jing Fang, Wenge Li, Min Tan, Xiangxin Peng, Zhao Tan, Wenbo Wang. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patientsInternational Journal of Rheumatic Diseases 2018; 21(5): 1060 doi: 10.1111/1756-185X.13313
28
Mortada HF El-Shabrawi, Sara Tarek, Maha Abou-Zekri, Safa Meshaal, Afaf Enayet, Engy Adel Mogahed. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income countryWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2020; 11(3): 48-58 doi: 10.4292/wjgpt.v11.i3.48
29
Filomena Morisco, Maria Guarino, Serena La Bella, Luisa Di Costanzo, Nicola Caporaso, Fabio Ayala, Nicola Balato. Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasisBMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0214-x
30
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, Antonio Ciaccio, Chiara Viganò, Andrea Palermo, Alessandra Zilli, Pietro Invernizzi, Silvio Danese. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and TricksInflammatory Bowel Diseases 2023; 29(9): 1477 doi: 10.1093/ibd/izac189